Spansules offers end to end , fully integrated drug development and manufacturing solutions and services to pharmaceutical companies.

By outsourcing certain aspects of drug development and manufacturing to Spansules you can reduce costs, accelerate time to market and ensure compliance with the regulatory standards. Spansules have enough manufacturing capacities to help you with your market demand.

shape

Formulation development

regulatory support

analytical method development

packing

supply

chain

quality assurance solutions

Are you looking to bring your pharmaceutical product to market efficiently and effectively? SPANSULES could be the solution you’ve been searching for. learn how this innovative approach can streamline the process from concept to commercialization!

shape

Pellets development and manufacturing

Pellets development and manufacturing offer a versatile and efficient way to deliver pharmaceutical compounds. These small, spherical units can be tailored to release drugs at specific rates, making them ideal for controlled-release formulations. By encapsulating active ingredients in pellets, manufacturers can enhance bioavailability and improve patient compliance.

The process of developing pellets involves formulation design, extrusion-spheronization, layering, and coating techniques. Each step is crucial in creating a final product that meets regulatory standards while optimizing therapeutic outcomes. With advancements in technology and expertise in pellet production, SPANSULES plays a key role in bringing these innovative drug delivery systems to market.

From initial concept development to scale-up manufacturing, SPANSULES specializing in pellets drug development provide comprehensive services to support every stage of the product lifecycle. Collaboration between pharmaceutical companies and experienced contract partners like Spansules is essential for successful technology transfer and commercialization efforts.

laboix image
laboix image

WHAT IS A CDMO?

  • Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the pharmaceutical industry by providing end-to-end solutions for drug development and manufacturing. These companies offer comprehensive services, from early-stage development to commercial production, helping pharmaceutical companies bring their products to market efficiently.

  • CDMOs have specialized expertise and state-of-the-art facilities that enable them to handle various aspects of drug development, including formulation development, process optimization, analytical testing, and regulatory compliance. By partnering with a CDMO, pharmaceutical companies can access specialized knowledge and resources without having to invest in expensive infrastructure themselves.

  • One of the key advantages of working with a CDMO is the ability to leverage their experience in navigating complex regulatory requirements. These organizations are well- versed in meeting stringent quality standards set by regulatory bodies worldwide, ensuring that products meet safety and efficacy criteria before reaching the market. Pharmaceutical companies can rely on CDMOs to streamline the drug development process while maintaining compliance with regulations.

  • CDMOs serve as strategic partners for pharmaceutical companies looking to accelerate product development timelines and improve operational efficiency. By outsourcing certain functions to a CDMO, pharmaceutical companies can focus on core competencies while benefiting from specialized expertise and flexible capacity options offered by these organizations.

back top